Finance

Regeneron Pharmaceuticals (NASDAQ: REGN) Investors Who Suffered Losses May Be Eligible to Participate in the Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses

Blue Gold Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency

Stock Market Today, July 27: Dow Rises on Oil Retreat, and Sandisk Plunges 11% on Memory Weakness

JPMorgan Sees S&P 500 Poised to Rally as New Buy Signal Flashes